Skip to content

Clinical evaluation of drug ablation combined with long pulse Nd: YAG 1064 nm laser sequential therapy in the treatment of onychomycosis

Clinical evaluation of drug ablation combined with long pulse Nd: YAG 1064 nm laser sequential therapy in the treatment of onychomycosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037753
Enrollment
Unknown
Registered
2020-08-31
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Interventions

Case series:drug ablation combine with laser treatment

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. According to the history, physical signs and laboratory examination, the patients with onychomycosis were diagnosed clinically; 2. Direct microscopic examination and / or fungal culture were positive; 3. Aged >=18 years old male and female; 4. Multiple nail involvement (>=4).

Exclusion criteria

Exclusion criteria: 1. Local exudation or combined with active bacteria and virus infection; 2. Those suffering from neuropsychiatric diseases or being treated with other drugs that affect the curative effect; 3. Psoriasis patients; 4. Patients who had been treated with antifungal agents or glucocorticoids within 4 weeks before enrollment; 5. Patients who had topical antifungal drugs within 2 weeks before enrollment; 6. Participants in other drug trials within 30 days before screening.

Design outcomes

Primary

MeasureTime frame
Onychomycosis Severity Index;Mycological detection;

Countries

China

Contacts

Public ContactTan Jingwen

Shanghai Skin Disease Hospital

cecilia88903@tongji.edu.cn+86 18017336766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026